Guelph, ON – September 20, 2021

ZEN Graphene Solutions Ltd. (“ZEN” or the “Company”) (TSX-V:ZEN and OTC:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, is pleased to announce that Chief Executive Officer, Greg Fenton will present at the Sidoti Fall Virtual Investor Conference, which is being held September 22 – 23, 2021.
 
Mr. Fenton will deliver his corporate presentation on Thursday, September 23 at 8:30 AM ET, and can be accessed live here: https://sidoti.zoom.us/webinar/register/WN_E941VllfQr24lpu2ktTpTA
 
Mr. Fenton will also be available for one-on-one meetings throughout the conference.
 
To register for the presentation or to schedule a one-on-one meeting:  https://www.sidoti.com/events
 
 
About ZEN Graphene Solutions Ltd.
 
ZEN is a nanotechnology company developing and commercializing next-gen healthcare solutions in the areas of prevention, detection and treatment. ZEN is currently focused on commercializing ZENGuardTM, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.
 
For further information:
Greg Fenton, Chief Executive Officer
Tel: 1(437) 220-8140
Email: gfenton@zengraphene.com
 
To find out more about ZEN Graphene Solutions Ltd., please visit our website at www.ZENGraphene.com. A copy of this news release and all material documents in respect of the Company may be obtained on ZEN’s SEDAR profile at www.sedar.ca.